These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12523630)

  • 21. Molecular characterization of amoxicillin-clavulanate resistance in a clinical isolate of Escherichia coli.
    Bellaaj A; Bollet C; Alfeddy N; Limam F; Belhadj C; Regli A; Chollet R; Belhadj O; Ben-Mahrez K
    Microb Drug Resist; 2002; 8(4):267-72. PubMed ID: 12523623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
    Singtohin S; Chanawong A; Lulitanond A; Sribenjalux P; Auncharoen A; Kaewkes W; Songsri J; Pienthaweechai K
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
    Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
    J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Wang Y; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.
    Winokur PL; Vonstein DL; Hoffman LJ; Uhlenhopp EK; Doern GV
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2716-22. PubMed ID: 11557460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase.
    Hentschke M; Kotsakis SD; Wolters M; Heisig P; Miriagou V; Aepfelbacher M
    Microb Drug Resist; 2011 Jun; 17(2):165-9. PubMed ID: 21388298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain.
    Porres-Osante N; Azcona-Gutiérrez JM; Rojo-Bezares B; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2014 Jul; 69(7):1792-5. PubMed ID: 24583362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transferable DHA-1 cephalosporinase in Escherichia coli.
    Giakkoupi P; Tambic-Andrasevic A; Vourli S; Skrlin J; Sestan-Crnek S; Tzouvelekis LS; Vatopoulos AC
    Int J Antimicrob Agents; 2006 Jan; 27(1):77-80. PubMed ID: 16352422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.
    Mavroidi A; Miriagou V; Malli E; Stefos A; Dalekos GN; Tzouvelekis LS; Petinaki E
    Int J Antimicrob Agents; 2012 Mar; 39(3):247-50. PubMed ID: 22226650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
    Briales A; Rodríguez-Martínez JM; Velasco C; de Alba PD; Rodríguez-Baño J; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2012 May; 39(5):431-4. PubMed ID: 22365240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 beta-lactamases.
    Colinon C; Miriagou V; Carattoli A; Luzzaro F; Rossolini GM
    J Antimicrob Chemother; 2007 Aug; 60(2):258-62. PubMed ID: 17540674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada.
    Allen KJ; Poppe C
    Can J Vet Res; 2002 Jul; 66(3):137-44. PubMed ID: 12146884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.
    Wachino J; Kurokawa H; Suzuki S; Yamane K; Shibata N; Kimura K; Ike Y; Arakawa Y
    Antimicrob Agents Chemother; 2006 Feb; 50(2):534-41. PubMed ID: 16436707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
    Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissemination of CTX-M-15 beta-lactamase genes carried on Inc FI and FII plasmids among clinical isolates of Escherichia coli in a university hospital in Istanbul, Turkey.
    Gonullu N; Aktas Z; Kayacan CB; Salcioglu M; Carattoli A; Yong DE; Walsh TR
    J Clin Microbiol; 2008 Mar; 46(3):1110-2. PubMed ID: 18184851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.